Lyell Immunopharma, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $10.7M | $-214.8M | $-250.2M |
| FY2022 | $84.7M | $-187.1M | $-183.1M |
| FY2023 | $130.0K | $-247.0M | $-234.6M |
| FY2024 | $61.0K | $-358.8M | $-343.0M |
| FY2025 | $36.0K | $-269.4M | $-274.4M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $10.7M | $-214.8M | $-250.2M |
| FY2022 | $84.7M | $-187.1M | $-183.1M |
| FY2023 | $130.0K | $-247.0M | $-234.6M |
| FY2024 | $61.0K | $-358.8M | $-343.0M |
| FY2025 | $36.0K | $-269.4M | $-274.4M |